JOHNSON KIM ANNE
No ORCID on file
· 32 papers in corpus
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…
2004
1. A metabolite of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol selected from the group consisting of: and stereoisomers, tautomers, regio and configurational isomers thereof and pharmaceutica…